{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:11:26Z","timestamp":1792026686943,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Applied Radiation and Isotopes"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.apradiso.2025.112190","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:24:01Z","timestamp":1758086641000},"page":"112190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Is 131I treatment necessary for postoperative DTC patients classified as intermediate- or high-risk with negative stimulated thyroglobulin?"],"prefix":"10.1016","volume":"226","author":[{"given":"Yao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canran","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5851-5945","authenticated-orcid":false,"given":"Caihua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.apradiso.2025.112190_bib1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/MNM.0b013e328362ad63","article-title":"Stunning phenomenon after a radioactive iodine- 131I diagnostic whole-body scan: is it really a point of clinical consideration?","volume":"34","author":"Amin","year":"2013","journal-title":"Nucl. Med. Commun."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112190_bib2","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.apradiso.2025.112190_bib3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1590\/2359-3997000000308","article-title":"Thyroglobulin levels before radioactive iodine therapy and dynamic risk stratification after 1 year in patients with differentiated thyroid cancer","volume":"61","author":"Bandeira","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.apradiso.2025.112190_bib4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.bjc.6603397","article-title":"Management of thyroid cancer and related nodular disease","volume":"95","author":"Cassoni","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"No. 3","key":"10.1016\/j.apradiso.2025.112190_bib5","article-title":"Guidelines for the diagnosis and management of thyroid nodules and differentiated thyroid cancer (Second edition)","volume":"39","year":"2023","journal-title":"Chin. J. Endocrinol. Metab."},{"key":"10.1016\/j.apradiso.2025.112190_bib6","first-page":"218","article-title":"Guidelines for radioiodine therapy of differentiated thyroid cancer (2021 edition)","volume":"41","year":"2021","journal-title":"Chin. J. Nucl. Med. Mol. Imag."},{"issue":"7","key":"10.1016\/j.apradiso.2025.112190_bib7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1089\/thy.2019.0753","article-title":"Is there a difference between minimal and gross extension into the strap muscles for the risk of recurrence in papillary thyroid carcinomas?","volume":"30","author":"Danilovic","year":"2020","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.apradiso.2025.112190_bib8","first-page":"1051","article-title":"Guidelines of Chinese socirty of clinicla Oncology (CSCO): persistents\/recurrent and metastatic Differentiates thyroid cancer - 2019","volume":"32","year":"2019","journal-title":"J. Cancer Control Treat."},{"issue":"1","key":"10.1016\/j.apradiso.2025.112190_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Nation. Cancer Center"},{"issue":"1","key":"10.1016\/j.apradiso.2025.112190_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.apradiso.2025.112190_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1089\/thy.2006.16.1229","article-title":"Outcomes of patients with differentiated thyroid carcinoma following initial therapy","volume":"16","author":"Jonklaas","year":"2006","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.apradiso.2025.112190_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.2010.03788.x","article-title":"Clinical outcomes of persistent radioiodine uptake in the neck shown by diagnostic whole body scan in patients with differentiated thyroid carcinoma after initial surgery and remnant ablation","volume":"73","author":"Kim","year":"2010","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"11","key":"10.1016\/j.apradiso.2025.112190_bib13","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00259-002-0945-8","article-title":"The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I","volume":"29","author":"Lees","year":"2002","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.apradiso.2025.112190_bib14","article-title":"Thyroid remnant estimation by diagnostic dose (131)I scintigraphy or ( 99m)TcO4(-) scintigraphy after thyroidectomy: a comparison with therap eutic dose (131)I imaging","volume":"2016","author":"Liu","year":"2016","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.apradiso.2025.112190_bib15","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2002-021702","article-title":"A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma","volume":"88","author":"Mazzaferri","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112190_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ecl.2014.02.010","article-title":"Update on differentiated thyroid cancer staging","volume":"43","author":"Momesso","year":"2014","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"5","key":"10.1016\/j.apradiso.2025.112190_bib17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/1097-0142(19880301)61:5<976::AID-CNCR2820610520>3.0.CO;2-U","article-title":"Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer","volume":"61","author":"M\u00fcller-G\u00e4rtner","year":"1988","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.apradiso.2025.112190_bib18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s12020-022-03021-y","article-title":"Value of stimulated pre-ablation thyroglobulin as a prognostic marker in patients with differentiated thyroid carcinoma treated with radioiodine","volume":"76","author":"N\u00f3brega","year":"2022","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.apradiso.2025.112190_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur. J. Endocrinol."},{"issue":"Suppl. 7","key":"10.1016\/j.apradiso.2025.112190_bib20","doi-asserted-by":"crossref","first-page":"vii110","DOI":"10.1093\/annonc\/mds230","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treat ment and follow-up","volume":"23","author":"Pacini","year":"2012","journal-title":"Ann. Oncol. : Offic. J. Europ. Soci. Med. Oncol."},{"issue":"3","key":"10.1016\/j.apradiso.2025.112190_bib21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1210\/jc.2009-1823","article-title":"Biallelic p.R2223H mutation in the thyroglobulin gene causes thyroglobulin retention and severe hypothyroidism with subsequent development of thyroid carcinoma","volume":"95","author":"Raef","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.apradiso.2025.112190_bib22","article-title":"The application of ultrasound in the diagnosis of thyroid postoperative scar tissue","volume":"37","author":"Rengaowa","year":"2015","journal-title":"J. Inner Mongolia Med. Univer."},{"issue":"11","key":"10.1016\/j.apradiso.2025.112190_bib23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1089\/thy.2012.0190","article-title":"Postoperative stimulated thyroglobulin of less than 1 ng\/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation","volume":"22","author":"Rosario","year":"2012","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.apradiso.2025.112190_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/eje.0.1510539","article-title":"Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice","volume":"151","author":"Schlumberger","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.apradiso.2025.112190_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-015-0660-4","article-title":"Value of post-therapeutic 131I scintigraphy in stimulated serum thyroglobulin-negative patients with metastatic differentiated thyroid carcinoma","volume":"51","author":"Shen","year":"2016","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.apradiso.2025.112190_bib26","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3892\/ol.2013.1639","article-title":"(99m)TcO(4)(-) scintigraphic detection of follicular thyroid cancer and multiple metastatic lesions: a case report","volume":"6","author":"Wang","year":"2013","journal-title":"Oncol. Lett."}],"container-title":["Applied Radiation and Isotopes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325005354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969804325005354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:12:07Z","timestamp":1769731927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969804325005354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"alternative-id":["S0969804325005354"],"URL":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.112190","relation":{},"ISSN":["0969-8043"],"issn-type":[{"value":"0969-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is 131I treatment necessary for postoperative DTC patients classified as intermediate- or high-risk with negative stimulated thyroglobulin?","name":"articletitle","label":"Article Title"},{"value":"Applied Radiation and Isotopes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apradiso.2025.112190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112190"}}